CacheBy
Thermo Fisher Scientific BCR-ABL Monoclonal Antibody (7C6)
원본

Thermo Fisher Scientific BCR-ABL Monoclonal Antibody (7C6)

상품 한눈에 보기

BCR-ABL 단백질을 인식하는 Mouse monoclonal antibody (Clone 7C6). Western blot, IHC, ICC, IP 등 다양한 응용에 사용 가능. Human 및 Mouse 반응성. Protein A 정제, PBS/BSA buffer에 보관. CML 연구용으로 적합.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오후 09:49
Thermo Fisher Scientific MA1153 BCR-ABL Monoclonal Antibody (7C6) 100 ug pk판매 단위 pk ·
재고 확인 필요
712,600원VAT 포함 783,860원

Thermo Fisher Scientific · Thermo Fisher Scientific BCR-ABL Monoclonal Antibody (7C6)

Applications and Tested Dilutions

Application Tested Dilution
Western Blot (WB) 1:500–1:1,000
Immunohistochemistry (Paraffin) (IHC-P) 1:50–1:500
Immunocytochemistry (ICC/IF) 1:50–1:100
Immunoprecipitation (IP) 5 µg

Product Specifications

항목 내용
Species Reactivity Human, Mouse
Published Species Human
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Clone 7C6
Immunogen Bcr686 thyroglobulin conjugate corresponding to human BCR sequence 686–696 (SSINEEITPRRQS)
Conjugate Unconjugated
Form Liquid
Concentration 1 mg/mL
Purification Protein A
Storage Buffer PBS with 1 mg/mL BSA
Contains 0.05% sodium azide
Storage Conditions -20°C
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2536861

Product Specific Information

Western blot analysis of MA1-153 detects ~130–160 kDa and a 210–250 kDa protein in K562 cells. In addition to BCR-ABL, BCR and ABL are also expressed in these cells, and full-length BCR is also detected by the antibody. Under non-reducing conditions, enhanced detection of BCR-ABL is observed.

Target Information

A reciprocal translocation between chromosomes 22 and 9 produces the BCR-ABL fusion oncoprotein, which is found in patients with chronic myelogenous leukemia (CML). The p210 form is the most common variant. The fusion leads to constitutive tyrosine kinase activation, driving oncogenic transformation of myeloid cells. Inhibition of BCR-ABL activity by the ABL-kinase inhibitor STI-571 (imatinib, Gleevec) represents a landmark in targeted cancer therapy. Mutations such as T351I have been associated with resistance, prompting further drug development.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.